A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Ulcerative Colitis Register Today!
ANB030-204: Ulcerative Colitis
Read More
mRNA-1283-P301 PART 2 Covid-19
A randomized, observer-blind, active-controlled Phase 3 study to investigate the safety, immunogenicity, and relative vaccine efficacy of mRNA-1283 compared with mRNA-1273 in participants aged ≥12 years for the prevention of COVID-19. Register Today!
B7981080
A phase 3 randomized, double-blind, 52-week placebocontrolled multi-center study with a double-blind 52-week extension period with randomized dose up/dose down titration investigating the efficacy, safety, and tolerability of Ritlecitinib in adult participants with nonsegmental vitiligo. Register Today!
Vaccine (RSV) – 222090 (extension to 212494)
A phase 3b, randomized, open label, multi-country, multi-center, extension and crossover vaccination study to evaluate the immunogenicity and safety of different revaccination schedules and persistence of a single dose of the RSVPreF3 OA vaccine in adults aged 60 years and above who participated in the RSV OA=ADJ-006 study. Register Today!
Jasmine DeCata
About Jasmine Jasmine began her nursing career in family medicine and quickly shifted to working in mental health and addiction. Recently, Jasmine’s path has led her to a new role at Medicor Research Inc. as a Research Assistant and Phlebotomist. She now balances her time between Medicor and caring for her busy family. Jasmine’s dedication…
Kaitlin McLean
About Kaitlin Kaitlin earned a Bachelor’s of Science degree from Laurentian University in 2018. She started with Medicor in October 2023 and has been working with Sudbury Dermatologists and Family Physicians on their clinical research studies since. She is excited to continue to learn about clinical trials and the industry.
Carolina Sanchez-Paz
About Carolina Carolina Sanchez Paz is originally from Ecuador, now based in Canada. A dedicated physician known for her compassionate approach to patient care, Carolina began her career in mental health and addictions, where she discovered her fervor for addressing the intricacies of the human mind and fostering healing in those facing mental health challenges….
Ella Cocco
About Ella Ella is a recent Biomedical Biology graduate from Laurentian University. Ella began with Medicor in the Spring of 2022 as a volunteer and later took on a position as a part-time Clinical Research Coordinator while completing her degree. Now graduated, Ella is excited to be working full-time with the company. Ella has worked…
Atopic Dermatitis – M16-047 (extension to M18-891)
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination with Topical Corticosteroids in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis For more information, please click here. Register Today!
Atopic Dermatitis – C4531002
Atopic dermatitis or eczema as it is commonly known, is a condition that makes your skin red and itchy. The disease is common in children but can also occur at any age. Eczema is a chronic condition that tends to flare up periodically. There is currently no cure for eczema, but treatments and self-care measures…